Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)

A Randomized, Double-masked, Multicenter, Controlled Study of Photodynamic Therapy in Patients With Central Serous Chorioretinopathy

The purpose of this study is to determine the safety and efficacy of PDT at 30% verteporfin dose in the treatment of CSC.

Inclusion Criteria:

• patients with CSC
• patients signed the ICF
• patients with course of CSC less than 6 months
• patients did not undertake any treatment for CSC

Exclusion Criteria:

• patients with porphyria
• patients allergic to verteporfin
• pregnant or nursing women
• poor patients compliance
• sever liver dysfunction
• dioptric media opacities which make it difficult to exam fundus